PNV in their pomp hit circa $3.90 when they were the next big med tech stock back in 2020. But at the time of writing their share price was 85.5c. Things are defiantly heading in the right direction with revenue, earnings, and profits all turning positive and growing substantially since 2020.
Consensus has a price target of $1.54 and based on FY27 estimated EPS or 3c, that is a PE of 51. Currently they are 85.5c per share and have a PEG 0.6 with EPS growth of 82.4% forecasted for the next 12-months. One for the truer believers here. Diffidently some upside in their share price but not sure if the market is prepared to pay 51 times earnings for them. But I could see a 30-40% gain in their share price from here if they can hit those growth targets. But you are always walking on a tightrope with high PE growth stocks, like PNV. Not for me, but for the more adventurous punter, you can see the appeal!
Disclaimer: Rational Share Investing With Ratios does not hold an AFSL and information on this site should not be considered financial advice, personal or general, and represents the views of the author.
Reference to specific securities (if any) is included for the purpose of illustration only and should not be construed as a recommendation to buy or sell the same. All securities mentioned herein may or may not form part of my holdings at a certain point in time, and the holdings may change over time.
Leave a Reply